Volume 8, Issue 12, December 2023
ISSN No:-2456-2165
Telemedicine and Remote Monitoring in Cirrhosis
Care: Revolutionizing Patient Management
1
Esha S. Rithe. 2J. V. Vyas; 3Dr. V. V. Paithankar; 4Dr. A.M. Wankhade
Abstract:- Liver cirrhosis, a relentless and progressive
liver ailment, poses distinctive challenges in patient care.
The paradigm of managing cirrhotic patients has
undergone a revolutionary shift with the integration of
telemedicine and remote monitoring technologies in
recent years. This review comprehensively examines the
profound impact of these advancements on cirrhosis
care, delving into their applications, benefits, and
associated challenges. Telemedicine facilitates remote
consultations, enabling patients to access specialized care
irrespective of geographical constraints. The proactive
monitoring afforded by these technologies empowers
cirrhotic patients with timely interventions, fostering
improved outcomes. As healthcare systems progressively
adopt these innovations, cirrhotic individuals stand to
gain from enhanced accessibility and a more patient-
centric approach, ultimately resulting in improved
health outcomes and a potential reduction in overall
healthcare costs. This transformative trajectory signifies
a positive shift toward comprehensive and
technologically augmented cirrhosis care.This review
article explores the impact of telemedicine and remote
monitoring on cirrhosis care, focusing on its
applications, benefits, and challenges. As healthcare
systems evolve to embrace these technologies, cirrhotic
patients can now receive more accessible and proactive
care, ultimately improving outcomes and reducing
healthcare costs.
Key Message: The integration of telemedicine and
remote monitoring technologies is a significant
breakthrough in the treatment of patients with liver
cirrhosis, a chronic and increasingly complicated liver
condition. This analysis emphasizes the transformative
impact of these technologies on cirrhosis management,
highlighting key takeaways for medical professionals,
policymakers, and the broader healthcare community.
Keywords:- Cirrhosis, telemedicine, telecommunications ,
telemonitoring, virtual communications.
I. INTRODUCTION
A crippling ailment, liver cirrhosis requires lifelong
care and observation. The extensive fibrosis and nodular
regeneration of the liver parenchyma are hallmarks of liver
cirrhosis, an irreversible and progressive condition.
Cirrhosis is a result of chronic liver injury, which can have
multiple etiologies, including autoimmune hepatitis,
alcohol-related liver disease, viral hepatitis, and non-
alcoholic fatty liver disease. It is the final stage of a liver
damage continuum. Affected liver function, portal
hypertension, and an increased risk of complications like
ascites, hepatic encephalopathy, variceal bleeding, and
hepatocellular carcinoma are caused by the disruption of the
IJISRT23DEC1111
International Journal of Innovative Science and Research Technology
hepatic architecture1,32. Excessive extracellular matrix
deposition is the end result of a complex pathogenesis that
includes hepatocyte injury, activation of hepatic stellate
cells, and inflammatory responses. To reduce complications
and enhance results, cirrhosis must be identified early and
managed appropriately. New developments in non-invasive
diagnostic methods, like serological markers and transient
elastography, help identify liver cirrhosis and fibrosis early.
Treatment plans also include controlling side effects,
treating the underlying cause, and, in severe cases, thinking
about liver transplantation 2.
The treatment of cirrhosis presents a variety of
difficulties, most of which are related to the disease's
chronic and progressive nature. Complications from
cirrhosis include hepatic encephalopathy, ascites, variceal
hemorrhage, and hepatocellular carcinoma are more
common in patients with the disease. To identify these
issues early and launch appropriate interventions, routine
monitoring is essential. However, patients may face
significant challenges as a result of this requirement for
regular medical evaluations, which frequently necessitates
lengthy hospital stays and interferes with daily activities.
Furthermore, it can be difficult for people living in rural or
underdeveloped areas to get specialized care, which can
cause delays in diagnosis and treatment3.
Telemedicine, as defined by the World Health
Organization, involves using modern tools like
telecommunications and virtual technology to deliver
healthcare services remotely outside of traditional hospital
settings. In the context of cirrhosis management,
telemedicine and remote monitoring technologies emerge as
transformative solutions4. By utilizing telecommunication
tools, healthcare providers can conduct virtual consultations,
allowing patients to receive expert guidance from a distance.
This not only improves access to specialized care but also
resolves logistical challenges associated with in-person
visits. Additionally, remote monitoring devices enable
continuous tracking of vital signs, liver function parameters,
and other important clinical data from the comfort of the
patient's home5. Real-time monitoring allows healthcare
providers to promptly detect subtle changes in the patient's
condition, enabling timely interventions and proactive
management strategies6.
II. TELEMEDICINE APPLICATIONS IN
CIRRHOSIS CARE
Telemedicine provides opportunities for cirrhotic
patients to consult with healthcare providers remotely. This
section discusses the following key applications:
www.ijisrt.com 1384
Volume 8, Issue 12, December 2023 International Journal of Innovative Science and Research Technology
A. Teleconsultations:
Teleconsultations have emerged as a valuable and
essential tool in the management of cirrhosis, effectively
overcoming barriers associated with geographical distance,
mobility constraints, and the need for frequent in-person
visits. This remote healthcare approach, particularly in the
context of hepatology, plays a pivotal role in providing
routine follow-ups, symptom management, and necessary
adjustments to medication regimens for individuals
grappling with cirrhosis.
In the realm of cirrhosis management, virtual
consultations with hepatologists offer a convenient solution
for patients who face challenges in regular travel to
healthcare facilities, often due to the severity of their
condition or other mobility issues. Through video or phone
consultations, hepatologists can conduct regular follow-ups,
ensuring continuous monitoring of the patient's well-being
without the necessity of in-person visits.By implementing
the Specialty Access Network-Extension for Community
Healthcare Outcomes (SCAN-ECHO) model, the Veterans
Health Administration (VA) system provides one of the
most well-known telemedicine interventions: specialty
consultation on case-based formats of new hepatitis C
treatment options to practitioners in underserved areas7.
Developed at the University of New Mexico, Argentina is
among the countries where the ECHO model has been
effectively implemented.8.
A significant advantage of teleconsultations is their
role in symptom management, a critical aspect of cirrhosis
care. Patients with cirrhosis frequently contend with
symptoms such as fatigue, gastrointestinal issues, and
complications like hepatic encephalopathy. Through remote
consultations, hepatologists can promptly assess and manage
these symptoms, providing timely guidance and making
necessary adjustments to the treatment plan based on the
evolving symptomatology.
Additionally, teleconsultations facilitate crucial
medication adjustments, contributing to the proactive
management of cirrhosis. Hepatologists can remotely review
medication adherence, assess the impact of prescribed drugs,
and make necessary adjustments to optimize regimens. This
proactive approach not only helps in mitigating potential
side effects but also addresses emerging issues promptly,
contributing to the overall effectiveness of the treatment
plan.
Teleconsultations in cirrhosis management offer a
comprehensive and patient centered approach, ensuring
accessibility to healthcare and timely interventions while
effectively addressing challenges associated with
geographical and mobility constraints9.
IJISRT23DEC1111 www.ijisrt.com
ISSN No:-2456-2165
B. Telemonitoring:
Continuous monitoring of vital signs, liver function, and
medication adherence from the patient's home. Through
telemonitoring, patients are observed from a distance in
order to look for objective data that could inform
management choices as well as signs and symptoms of the
disease's progression. In the perioperative period after liver
transplantation, smart tablets have been utilized in this way
to monitor laboratory results, weight, and vital signs in
pediatric liver transplant patients10,11 . Validation has been
achieved for a smartphone-based Stroop test for the
detection of covert hepatic encephalopathy12. Comparably, a
"Patient Buddy App" that monitors symptoms like weight
gain, medication compliance, and salt intake each day has
demonstrated potential in lowering hepatic encephalopathy-
related hospital readmissions13. A novel program that
employed a telehealth platform equipped with wireless
blood pressure monitors, pulse oximeters, 4-G tablets, and
scales proved effective in remotely monitoring patients for
decompensation symptoms and indicators like bleeding,
infections, hepatic encephalopathy, and fluid overload.
Preventable readmissions were reduced from 33.8% in the
standard of care arm to 0% in the intervention arm at 30 and
90 days. This tactic illustrated how telemonitoring can
improve patient-centered care while reducing 30- and 90-
day readmissions14.
C. Education and Counselling:
Education and counselling play crucial roles in the
comprehensive management of chronic conditions such as
cirrhosis. Telemedicine allows healthcare providers to
deliver educational content to cirrhotic patients remotely.
Through online platforms, patients can access resources that
cover various aspects of cirrhosis, including lifestyle
modifications, dietary guidelines, medication adherence, and
information about potential complications. This educational
outreach not only enhances patients' understanding of their
condition but also equips them with the knowledge
necessary for self-management15.
III. REMOTE MONITORING TECHNOLOGIES
Remote monitoring technologies are devices or
applications that can measure and transmit health-related
data from patients to their health care providers. They can
help patients with liver cirrhosis to manage their condition,
prevent complications, and improve their quality of life.
Some examples of remote monitoring technologies for liver
cirrhosis are:
 Smartphone-based apps and Wearable sensors :For
many patients, the available healthcare is insufficient and
dispersed. Through the use of smartphones for remote
health monitoring, it is possible to identify physiological
abnormalities early on, decrease hospitalizations, and
enhance long-term outcomes for patients with cirrhosis
who may present with predictable red flags that lead to
hospitalization 16.
1385
Volume 8, Issue 12, December 2023 International Journal of Innovative Science and Research Technology
ISSN No:-2456-2165

Fig. 1: Hypothetical use of a mobile health platform for cognitive assessment in cirrhosis, leveraging technology to better
diagnose and manage encephalopathy16.

Studies have suggested that smartphone-based remote
monitoring may be useful for people with decompensated
cirrhosis. A significant percentage of English-speaking
patients receiving hepatology care at our academic centers
reported using their smartphones extensively, which is
defined as using all of the device's features. Smartphone
users were more likely to be younger, married, jobless, live
in higher-income zip codes, and have non-alcoholic cirrhosis
etiology. It's interesting to note that most patients expressed
interest in smartphone-based remote health monitoring
applications, irrespective of their use of smartphones or
hepatic encephalopathy. Notably, a large percentage of
patients did not have a spouse or long-term partner, and
hepatic encephalopathy was common among smartphone
users. In order to improve liver-related outcomes, these
clinical and sociodemographic findings may serve as a basis
for the future development of focused remote health
applications for people with decompensated cirrhosis17.

Table 1: Sociodemographic Data of Decompensated Cirrhosis Patients by Smartphone Type17

 Home-Based LaboratoryTests: Tools for self-
administered blood tests and the monitoring of liver
function. Home-based blood tests are tests that allow
people to measure their blood levels of certain
biomarkers at home, using a device or a kit that collects
a small sample of blood, usually from a finger prick. The
sample is then sent to a laboratory for analysis, or the
device can provide instant results. Home-based blood
tests can be useful for people with liver cirrhosis, as they
can help them monitor their liver function and prevent

IJISRT23DEC1111 www.ijisrt.com 1386

Volume 8, Issue 12, December 2023
complications, without having to visit the hospital
frequently.
 Some examples of home-based blood tests for liver
cirrhosis are:
 Bilirubin test:This test quantifies the amount of
bilirubin, a yellow pigment produced when red blood
cells degrade. Elevations in bilirubin levels may signify
harm to the liver and result in jaundice, or the yellowing
of the skin and eyes.A home-based bilirubin test can use
a device that measures the color of the skin, or a strip
that changes color when dipped in urine18.
 Albumin test: This test measures the level of albumin, a
protein that the liver produces. Low levels of albumin
can indicate liver damage and cause fluid retention, or
swelling of the legs and abdomen. A home-based
albumin test can use a device that measures the electrical
Fig. 2: Potential applications of mobile and wearable technology to detect various complications of cirrhosis22
IV. IDEAL TELEMEDICINE APPROACH
An ideal telemedicine approach for cirrhosis
management encompasses the following key elements:
 User-Friendly Technology: Utilize user-friendly
telehealth platforms that are easily accessible to patients.
The technology should be intuitive, accommodating
various levels of digital literacy. This ensures a seamless
experience for both healthcare providers and patients23.
 Remote Monitoring Devices: Integrate remote
monitoring devices for continuous tracking of vital signs
and liver function. Wearable devices and home-based
monitoring tools provide real-time data, enabling
proactive intervention and personalized care plans.
 Secure Communication Channels: Prioritize secure
communication channels to ensure patient data privacy.
Compliance with data protection regulations and the
implementation of encryption mechanisms are essential
IJISRT23DEC1111 www.ijisrt.com
International Journal of Innovative Science and Research Technology
ISSN No:-2456-2165
conductivity of the blood, or a strip that changes colour
when dipped in blood19.
 Prothrombin time (PT) test:The duration needed for
the blood to clot is measured in this test. Clotting factors
are produced by the liver and aid in halting bleeding. An
elevated PT may be a sign of liver damage and raise the
chance of bleeding.A home-based PT test can use a
device that measures the optical density of the blood, or
a strip that changes colour when dipped in blood20.
 Home-based blood tests: can provide convenience,
privacy, and cost-effectiveness for people with liver
cirrhosis. However, they also have some limitations,
such as accuracy, reliability,and interpretation of results.
Therefore, people who use home-based blood tests
should always consult their doctor before making any
changes to their treatment or lifestyle21.
to build trust and maintain the confidentiality of medical
information .
 Multidisciplinary Care Teams: Establish
multidisciplinary care teams involving hepatologists,
nurses, dietitians, and mental health professionals. This
collaborative approach ensures comprehensive care,
addressing medical, nutritional, and psychosocial aspects
of cirrhosis management 24.
 Patient Education and Counselling: Incorporate virtual
educational resources and counselling sessions into the
telemedicine framework. Providing patients with
information about their condition and offering emotional
support enhances their understanding and ability to
manage cirrhosis effectively25.
 Integration with Electronic Health Records
(EHR):Ensure seamless integration with electronic
health records for efficient information exchange
between telemedicine encounters and in-person visits.
1387
Volume 8, Issue 12, December 2023 International Journal of Innovative Science and Research Technology
This integration promotes continuity of care and a
comprehensive view of the patient's medical history 26.
 The Patient Perspective on Telemedicine: People
generally accept telemedicine well. In a cross-sectional
investigation involving over a million patients carried
out in the J. D. Prior to the COVID-19 pandemic,
telemedicine was linked to high levels of patient
satisfaction even in the face of obstacles like video
consultations with providers and restricted service
availability. That is not to argue that issues didn't arise.
More than one-third of the patients who were surveyed
Fig. 3: Patient satisfaction with telemedicine27
V. CHALLENGES AND LIMITATIONS IN THE
IMPLEMENTATION OF TELEMEDICINE IN
CIRRHOSIS MANAGEMENT
 Technological Barriers :The widespread adoption of
telemedicine faces challenges related to technological
barriers, particularly in terms of patient access and
proficiency with technology. Disparities in the way
healthcare is provided could arise from the fact that some
patients may not have equal access to the required
equipment or a dependable internet
connection.Moreover, some patients, especially in older
demographics, may lack the proficiency to navigate and
effectively utilize telemedicine platforms. Addressing
these issues is essential to ensure equitable access to care
and the successful implementation of telemedicine in
cirrhosis management 29.
 Data Security: Ensuring the privacy and security of
patient data is a paramount concern in telemedicine.
Emphasizes the importance of robust data security
measures to safeguard patient information during remote
consultations, monitoring, and interactions. Striking the
right balance between accessibility and security is crucial
to build trust among patients and healthcare providers.
Implementing encryption, secure communication
channels, and compliance with data protection
regulations are essential components of a robust data
security strategy in telemedicine for cirrhosis
management 30.
IJISRT23DEC1111 www.ijisrt.com
ISSN No:-2456-2165
reported having a problem during their visit, which left
many of them feeling unsatisfied. While telemedicine
can eliminate certain obstacles, like having to travel and
pay for parking, it also creates new ones, like making it
harder to access or understand the systems required for
telehealth. There are numerous methods for getting past
these obstacles. One way to help patients with telehealth
is to arrange an orientation call beforethe telemedicine
visit to make sure everyone is aware of the fees, how to
pay, and what services will be rendered28.
 Regulatory and Reimbursement Issues : highlights the
legal and financial considerations surrounding
telemedicine, which can pose challenges to its
widespread implementation. Regulatory frameworks
may vary, affecting the licensure of healthcare providers
delivering telemedicine services across different regions.
Additionally, reimbursement policies may not be
uniformly established, impacting the financial
sustainability of telemedicine programs. Addressing
these regulatory and reimbursement issues is critical to
fostering the integration of telemedicine into mainstream
healthcare practices and ensuring its viability as a long-
term solution for cirrhosis management31.
VI. FUTURE DIRECTIONS AND CONCLUSION
Future directions in cirrhosis care involve the
integration of artificial intelligence (AI) and machine
learning (ML) into telemedicine and remote monitoring.
These advancements promise more personalized and
proactive interventions by analyzing complex datasets for
early complication detection. As technology evolves,
telemedicine is poised to become increasingly crucial in
cirrhosis management, breaking down barriers to healthcare
access. The transformative potential of these technologies is
anticipated to significantly enhance patient outcomes,
marking a paradigm shift towards more effective and
patient-centric cirrhosis care. This review underscores the
pivotal role of telemedicine and remote monitoring,
1388
Volume 8, Issue 12, December 2023
forecasting a future where technology revolutionizes the
lives of cirrhotic patients. It also focus on telemedicine and
remote monitoring in cirrhosis care highlights the
transformative potential of these technologies in the
management of this challenging condition, ultimately
leading to improved patient care and outcomes.
REFERENCES
[1]. Arroyo V, Moreau R, Kamath PS, Jalan R, Ginès P,
Nevens F, Fernández J, To U, García-Tsao G, Schnabl
B. Acute-on-chronic liver failure in cirrhosis. Nature
reviews Disease primers. 2016 Jun 9;2(1):1-8.
[2]. Friedman SL, Neuschwander-Tetri BA, Rinella M,
Sanyal AJ. Mechanisms of NAFLD development and
therapeutic strategies. Nature medicine. 2018
Jul;24(7):908-22.
[3]. Garcia‐Tsao G, Abraldes JG, Berzigotti A, Bosch J.
Portal hypertensive bleeding in cirrhosis: Risk
stratification, diagnosis, and management: 2016
practice guidance by the American Association for the
study of liver diseases.
[4]. Hepatology. 2017 Jan 1;65(1):310-35.
[5]. World Health Organization. Telemedicine:
opportunities and developments in member states.
Report on the second global survey on eHealth. World
Health Organization; 2010.
[6]. Kalo E, Baig A, Gregg E, George J, Read S, Ma WS,
Ahlenstiel G. A novel, nurse-led ‘one stop’clinic for
patients with liver cirrhosis results in fewer liver-
related unplanned readmissions and improved survival.
BMC gastroenterology. 2023 Oct 16;23(1):356.
[7]. Tapper EB, Volk M. Strategies to reduce 30-day
readmissions in patients with cirrhosis. Current
gastroenterology reports. 2017 Jan;19:1-7.
[8]. Arora S, Kalishman S, Thornton K, Dion D, Murata G,
Deming P, Parish B, Brown J, Komaromy M, Colleran
K, Bankhurst A. Expanding access to hepatitis C virus
treatment—Extension for Community Healthcare
Outcomes (ECHO) project: disruptive innovation in
specialty care. Hepatology. 2010 Sep;52(3):1124-33.
[9]. Marciano S, Haddad L, Plazzotta F, Mauro E, Terraza
S, Arora S, Thornton K, Ríos B, García Dans C,
Ratusnu N, Calanni L. Implementation of the ECHO®
telementoring model for the treatment of patients with
hepatitis C. Journal of medical virology. 2017
Apr;89(4):660-4.
[10]. Kalo E, Baig A, Gregg E, George J, Read S, Ma WS,
Ahlenstiel G. A novel, nurse-led ‘one stop’clinic for
patients with liver cirrhosis results in fewer liver-
related unplanned readmissions and improved survival.
BMC gastroenterology. 2023 Oct 16;23(1):356.
[11]. Ertel AE, Kaiser TE, Abbott DE, Shah SA. Use of
video-based education and tele-health home
monitoring after liver transplantation: results of a novel
pilot study. Surgery. 2016 Oct 1;160(4):869-76.
[12]. Song B, Schulze M, Goldschmidt I, Haux R, Baumann
U, Marschollek M. Home monitoring and decision
support for international liver transplant children.
InMEDINFO 2013: proceedings of the 14th World
Congress on Medical and Health Informatics 2013 (pp.
268-272).
IJISRT23DEC1111 www.ijisrt.com
International Journal of Innovative Science and Research Technology
ISSN No:-2456-2165
[13]. Bajaj JS, Heuman DM, Sterling RK, Sanyal AJ,
Siddiqui M, Matherly S, Luketic V, Stravitz RT, Fuchs
M, Thacker LR, Gilles H. Validation of EncephalApp,
smartphone-based Stroop test, for the diagnosis of
covert hepatic encephalopathy. Clinical
Gastroenterology and Hepatology. 2015 Oct
1;13(10):1828-35.
[14]. Ganapathy D, Acharya C, Lachar J, Patidar K, Sterling
RK, White MB, Ignudo C, Bommidi S, DeSoto J,
Thacker LR, Matherly S. The patient buddy app can
potentially prevent hepatic encephalopathy‐related
readmissions. Liver International. 2017
Dec;37(12):1843-51..
[15]. Khungar V, Serper M, Peyton D, Mehta S, Norris A,
Huffenberger A, Siddique SM, Forde-McLean KA.
Use of an innovative telehealth platform to reduce
readmissions and enable patient-centered care in
cirrhotic patients. InHepatology 2017 Oct 1 (Vol. 66,
pp. 94A-95A). 111 RIVER ST, HOBOKEN 07030-
5774, NJ USA: WILEY.
[16]. Kalo E, Baig A, Gregg E, George J, Read S, Ma WS,
Ahlenstiel G. A novel, nurse-led ‘one stop’clinic for
patients with liver cirrhosis results in fewer liver-
related unplanned readmissions and improved survival.
BMC gastroenterology. 2023 Oct 16;23(1):356.
[17]. Torous J, Kiang MV, Lorme J, Onnela JP. New tools
for new research in psychiatry: a scalable and
customizable platform to empower data driven
smartphone research. JMIR mental health. 2016 May
5;3(2):e5165.
[18]. Sack J, Hashemi N. Smartphone-Based Remote Health
Monitoring—Implications for Healthcare Delivery in
Patients with Cirrhosis. Journal of General Internal
Medicine. 2019 Dec;34:2726-7.
[19]. Bajaj JS, Heuman DM, Sterling RK, Sanyal AJ,
Siddiqui M, Matherly S, Luketic V, Stravitz RT, Fuchs
M, Thacker LR, Gilles H. Validation of EncephalApp,
smartphone-based Stroop test, for the diagnosis of
covert hepatic encephalopathy. Clinical
Gastroenterology and Hepatology. 2015 Oct
1;13(10):1828-35.
[20]. Ganapathy D, Acharya C, Lachar J, Patidar K, Sterling
RK, White MB, Ignudo C, Bommidi S, DeSoto J,
Thacker LR, Matherly S. The patient buddy app can
potentially prevent hepatic encephalopathy‐related
readmissions. Liver International. 2017
Dec;37(12):1843-51.
[21]. Khungar V, Serper M, Peyton D, Mehta S, Norris A,
Huffenberger A, Siddique SM, Forde-McLean KA.
Use of an innovative telehealth platform to reduce
readmissions and enable patient-centered care in
cirrhotic patients. InHepatology 2017 Oct 1 (Vol. 66,
pp. 94A-95A). 111 RIVER ST, HOBOKEN 07030-
5774, NJ USA: WILEY.
[22]. Sack J, Hashemi N. Smartphone-Based Remote Health
Monitoring—Implications for Healthcare Delivery in
Patients with Cirrhosis. Journal of General Internal
Medicine. 2019 Dec;34:2726-7.
[23]. Bajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS,
Garcia‐Tsao G, Maliakkal B, Biggins SW, Thuluvath
PJ, Fallon MB, Subramanian RM. The 3‐month
1389
Volume 8, Issue 12, December 2023 International Journal of Innovative Science and Research Technology
ISSN No:-2456-2165
readmission rate remains unacceptably high in a large
North American cohort of patients with cirrhosis.
Hepatology. 2016 Jul 1;64(1):200-8.
[24]. Whitten PS, Mackert MS. Addressing telehealth's
foremost barrier: provider as initial gatekeeper.
International journal of technology assessment in
health care. 2005 Oct;21(4):517-21.
[25]. Liu CH, Kao JH. Reply to:“Sofosbuvir and the risk of
kidney dysfunction”. Journal of Hepatology. 2021 Jan
1;74(1):257-8.
[26]. Seo MH, Lee WY, Kim SS, Kang JH, Kang JH, Kim
KK, Kim BY, Kim YH, Kim WJ, Kim EM, Kim HS.
2018 Korean society for the study of obesity guideline
for the management of obesity in Korea. Journal of
obesity & metabolic syndrome. 2019 Mar;28(1):40.
[27]. Fisk M, Livingstone A, Pit SW. Telehealth in the
context of COVID-19: changing perspectives in
Australia, the United Kingdom, and the United States.
Journal of medical Internet research. 2020 Jun
9;22(6):e19264.
[28]. Hoyt K, Reynolds A. The patient perspective on
telemedicine. Clinical Liver Disease. 2022
Apr;19(4):167.
[29]. Power JD. Telehealth Patient Satisfaction Surges
During Pandemic but Barriers to Access Persist. JD
Power.
[30]. Bashshur R, Shannon G, Krupinski E, Grigsby J. The
taxonomy of telemedicine. Telemedicine and e-Health.
2011 Jul 1;17(6):484-94.
[31]. Kang YK, Yook JH, Park YK, Kim YW, Kim J, Ryu
MH, Rha SY, Chung IJ, Kim IH, Oh SC, Yoo CH.
Phase III randomized study of neoadjuvant
chemotherapy (CT) with docetaxel (D), oxaliplatin (O)
and S-1 (S)(DOS) followed by surgery and adjuvant S-
1, vs surgery and adjuvant S-1, for resectable advanced
gastric cancer (GC)(PRODIGY). Annals of Oncology.
2019 Oct 1;30:v876-7.
[32]. Wosik J, Fudim M, Cameron B, Gellad ZF, Cho A,
Phinney D, Curtis S, Roman M, Poon EG, Ferranti J,
Katz JN. Telehealth transformation: COVID-19 and
the rise of virtual care. Journal of the American
Medical Informatics Association. 2020 Jun;27(6):957-
62.
[33]. O’Connell MB, Bendtsen F, Nørholm V, Brødsgaard
A, Kimer N. Nurse-assisted and multidisciplinary
outpatient follow-up among patients with
decompensated liver cirrhosis: A systematic review.
Plos one. 2023 Feb 9;18(2):e0278545.

IJISRT23DEC1111 www.ijisrt.com 1390